德克萨斯州公共保险女性产后避孕:使用与偏好的比较
该前瞻性队列研究纳入德克萨斯州八家医院的1700名18-44岁女性,在产后即刻及3、6个月访谈,评估产后避孕偏好与实际使用的差异。约80%完成3和6个月访谈(1367/1700),长效可逆避孕(LARC)偏好40.8%(547例)而使用21.9%(293例),绝育偏好36.1%(484例)而使用17.5%(235例)。结论认为长效和永久避孕方法使用有限与医疗服务提供者和系统层面障碍指标相关,扩大产后即刻LARC提供及未登记女性避孕覆盖可缩小偏好与使用的差距。
要点
- 产后LARC偏好40.8%(547例)高于使用21.9%(293例),绝育偏好36.1%(484例)高于使用17.5%(235例)。
- 想再生育且有LARC偏好者,在提供产后即刻LARC的医院使用率更高(P<.035)。
- 不想再生育者中,偏好长效或永久方法的使用因医院而异(P<.001),黑人女性使用较低(OR 0.26,95% CI 0.12-0.55)。
核心结论
- 产后长效和永久避孕方法使用有限与医疗服务提供者和系统层面障碍指标相关。
- 扩大产后即刻LARC提供及未登记女性避孕覆盖可缩小偏好与使用的差距。
研究设计与样本
- 前瞻性队列研究,纳入德克萨斯州八家医院1700名18-44岁希望推迟生育至少2年的女性,产后即刻及3、6个月访谈。
- 3个月时询问6个月时希望使用的避孕方法以评估偏好。
- 采用混合效应逻辑回归建模高效避孕偏好及基于偏好的使用,检验医院间变异及有无产后即刻LARC提供的差异。
主要发现
- 约80%完成3和6个月访谈(1367/1700)。
- 总体LARC偏好40.8%(n=547)高于使用21.9%(n=293),绝育偏好36.1%(n=484)高于使用17.5%(n=235)。
- 想再生育女性中,若干人口学变量与LARC偏好相关,但医院间无显著变异。
- 想再生育且有LARC偏好者,在提供产后即刻LARC的医院使用更高(P<.035);美国出生女性OR 2.08(95% CI 1.17-3.69),公共产前保健提供者女性OR 2.04(95% CI 1.13-3.69)。
- 不想再生育者中,长效或永久方法偏好医院间无显著变异,但基于偏好的使用因医院而异(P<.001);黑人女性OR 0.26(95% CI 0.12-0.55),美国出生女性OR 2.32(95% CI 1.36-3.96),30岁及以上OR 1.82(95% CI 1.07-3.09),公共产前保健提供者女性OR 2.04(95% CI 1.18-3.51)。
关键数值与推荐
- LARC偏好40.8%(n=547)对比使用21.9%(n=293)。
- 绝育偏好36.1%(n=484)对比使用17.5%(n=235)。
- 想再生育且有LARC偏好者,提供产后即刻LARC的医院使用更高(P<.035)。
- 不想再生育者中基于偏好的使用因医院而异(P<.001)。
临床怎么用
- 原文结论指出扩大产后即刻LARC提供及未登记女性避孕覆盖可缩小偏好与使用的差距。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess women's preferences for contraception after delivery and to compare use with preferences. METHODS: In a prospective cohort study of women aged 18-44 years who wanted to delay childbearing for at least 2 years, we interviewed 1,700 participants from eight hospitals in Texas immediately postpartum and at 3 and 6 months after delivery. At 3 months, we assessed contraceptive preferences by asking what method women would like to be using at 6 months. We modeled preference for highly effective contraception and use given preference according to childbearing intentions using mixed-effects logistic regression testing for variability across hospitals and differences between those with and without immediate postpartum long-acting reversible contraception (LARC) provision. RESULTS: Approximately 80% completed both the 3- and 6-month interviews (1,367/1,700). Overall, preferences exceeded use for both-LARC: 40.8% (n=547) compared with 21.9% (n=293) and sterilization: 36.1% (n=484) compared with 17.5% (n=235). In the mixed-effects logistic regression models, several demographic variables were associated with a preference for LARC among women who wanted more children, but there was no significant variability across hospitals. For women who wanted more children and had a LARC preference, use of LARC was higher in the hospital that offered immediate postpartum provision (P<.035) as it was for U.S.-born women (odds ratio [OR] 2.08, 95% CI 1.17-3.69) and women with public prenatal care providers (OR 2.04, 95% CI 1.13-3.69). In the models for those who wanted no more children, there was no significant variability in preferences for long-acting or permanent methods across hospitals. However, use given preference varied across hospitals (P<.001) and was lower for black women (OR 0.26, 95% CI 0.12-0.55) and higher for U.S.-born women (OR 2.32, 95% CI 1.36-3.96), those 30 years of age and older (OR 1.82, 95% CI 1.07-3.09), and those with public prenatal care providers (OR 2.04, 95% CI 1.18-3.51). CONCLUSION: Limited use of long-acting and permanent contraceptive methods after delivery is associated with indicators of health care provider and system-level barriers. Expansion of immediate postpartum LARC provision as well as contraceptive coverage for undocumented women could reduce the gap between preference and use.
引用
- Potter JE, Coleman-Minahan K, White K, et al. Contraception After Delivery Among Publicly Insured Women in Texas: Use Compared With Preference. Obstet Gynecol. 2017. PMID: 28697112. doi:10.1097/AOG.0000000000002136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。